Jim Petrilla, founding CEO of BioAgilytix Labs in Durham, North Carolina, has been named CEO and board director at Colchester-based Vernal Biosciences, a leader in mRNA and lipid nanoparticle development, manufacturing and analytics.
Petrilla succeeds founding CEO Christian Cobaugh, who will continue with the company as chief scientific officer and board director, focusing on advancing Vernal’s scientific and technological capabilities to further excellence in innovation.
“We are thrilled to welcome Jim to Vernal Biosciences,” Cobaugh said. “His proven ability to deliver innovative and impactful solutions in the life sciences sector aligns perfectly with our customers' needs. We are confident Jim's leadership will enable Vernal’s expansion of mRNA offerings and expertly scale our operations, enhancing our approach to addressing customers' R&D challenges and accelerating the delivery of transformative therapies.”